[Role of dynamic contrast-enhanced MR mammography imaging in the diagnosis of breast tumors].
Potential of contrast-enhanced MR imaging (MRI) in diagnosis of breast tumors was studied in 112 patients aged 18-64 (76 suspects and 36--after combined treatment). The method proved highly-effective and specific--92 and 81%, respectively. The best timing was 3 months after surgery and 8 months after irradiation. No significant advantage of either one- or polymolar contrast agents was observed. MRI is highly efficient in diagnosing hypervascular formations, tumor grading and making prognosis. It is a method of choice in evaluating neoadjuvant polychemotherapy findings and combined treatment monitoring.